Patricia Ann Duffy

Array ( [id] => 8807631 [patent_doc_number] => 08445283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Methods for producing biological substances in enzyme-deficient mutants of Aspergillus niger' [patent_app_type] => utility [patent_app_number] => 12/823046 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17505 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12823046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596445 [patent_doc_number] => 07982006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Clostridium perfringens alpha toxin proteins' [patent_app_type] => utility [patent_app_number] => 12/821815 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 17711 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982006.pdf [firstpage_image] =>[orig_patent_app_number] => 12821815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187875 [patent_doc_number] => 20110171252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Streptococcus suis vaccines and diagnostic tests' [patent_app_type] => utility [patent_app_number] => 12/802966 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 22461 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171252.pdf [firstpage_image] =>[orig_patent_app_number] => 12802966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007097 [patent_doc_number] => 20110059128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE (CIRD)' [patent_app_type] => utility [patent_app_number] => 12/816214 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18937 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059128.pdf [firstpage_image] =>[orig_patent_app_number] => 12816214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908996 [patent_doc_number] => 08481055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides' [patent_app_type] => utility [patent_app_number] => 12/786326 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19960 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12786326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195565 [patent_doc_number] => 20110027319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'METHODS OF ELICITING OR BOOSTING A CELLULAR IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/783491 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11534 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027319.pdf [firstpage_image] =>[orig_patent_app_number] => 12783491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209014 [patent_doc_number] => 20120128680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'BIOMARKER ANTIBODY AND DIAGNOSIS DEVICE FOR DETECTING CERTAIN AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/319207 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6748 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128680.pdf [firstpage_image] =>[orig_patent_app_number] => 13319207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184129 [patent_doc_number] => 20120114657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa' [patent_app_type] => utility [patent_app_number] => 13/262791 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8498 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114657.pdf [firstpage_image] =>[orig_patent_app_number] => 13262791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323401 [patent_doc_number] => 20100196948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHOD OF SCREENING BAFF SUPPRESSOR OR INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/751307 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5502 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196948.pdf [firstpage_image] =>[orig_patent_app_number] => 12751307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817486 [patent_doc_number] => 20120064106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'FLAGELLIN FUSION PROTEINS AND USE THEREOF TO INDUCE IMMUNE RESPONSES AGAINST PSEUDOMONAS AERUGINOSA' [patent_app_type] => utility [patent_app_number] => 13/256882 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22822 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064106.pdf [firstpage_image] =>[orig_patent_app_number] => 13256882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662293 [patent_doc_number] => 20110311562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Glycolipid Mixture with Anti-Inflammatory Activity Obtained from Oscillatoria Planktothrix' [patent_app_type] => utility [patent_app_number] => 13/201967 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8916 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311562.pdf [firstpage_image] =>[orig_patent_app_number] => 13201967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992537 [patent_doc_number] => 20110014190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE' [patent_app_type] => utility [patent_app_number] => 12/705551 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32999 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014190.pdf [firstpage_image] =>[orig_patent_app_number] => 12705551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6438122 [patent_doc_number] => 20100144058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'B-LYMPHOCYTE STIMULATOR BINDING POLYPEPTIDES AND METHODS BASED THEREON' [patent_app_type] => utility [patent_app_number] => 12/701301 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88355 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144058.pdf [firstpage_image] =>[orig_patent_app_number] => 12701301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6498932 [patent_doc_number] => 20100209905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'PROTEIN D - AN IGD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE' [patent_app_type] => utility [patent_app_number] => 12/696733 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7181 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209905.pdf [firstpage_image] =>[orig_patent_app_number] => 12696733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23347 [patent_doc_number] => 07794979 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Solubility tags for the expression and purification of bioactive peptides' [patent_app_type] => utility [patent_app_number] => 12/692665 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 18847 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794979.pdf [firstpage_image] =>[orig_patent_app_number] => 12692665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7686089 [patent_doc_number] => 20100120052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Orotate Transporter Encoding Marker Genes' [patent_app_type] => utility [patent_app_number] => 12/688303 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16674 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120052.pdf [firstpage_image] =>[orig_patent_app_number] => 12688303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228811 [patent_doc_number] => 20100183549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'BACTERIAL VACCINES WITH CELL WALL-ASSOCIATED CERAMIDE-LIKE GLYCOLIPIDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/684685 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27635 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183549.pdf [firstpage_image] =>[orig_patent_app_number] => 12684685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817488 [patent_doc_number] => 20120064108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'GLYCOCONJUGATE VACCINES' [patent_app_type] => utility [patent_app_number] => 13/258722 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16773 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064108.pdf [firstpage_image] =>[orig_patent_app_number] => 13258722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527265 [patent_doc_number] => 08043857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Recombinant BCG strains with enhanced ability to escape the endosome' [patent_app_type] => utility [patent_app_number] => 12/650606 [patent_app_country] => US [patent_app_date] => 2009-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 44 [patent_no_of_words] => 23563 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/043/08043857.pdf [firstpage_image] =>[orig_patent_app_number] => 12650606 [rel_patent_id] =>[rel_patent_doc_number] =>)